Validation Changes to the USP Assay Method for Ibuprofen Tablets

Velagaleti,Ranga;Ward,James;Anderson,Pam;Massad,Lynn;Burns,Philip;

Validation Changes to the USP Assay Method for Ibuprofen Tablets

March 1, 2002

By Ranga Velagaleti, PhD
James Ward

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-03-02-2002

Volume 26

Issue 3

This study investigated the effectiveness of the direct extraction of tablets and shaking time on the disintegration of tablets, solubilization, and recovery of ibuprofen from tablets of various formulations, strengths, and spiked placebo.

External Link - article-12527.pdf

Articles in this issue

Outsourcing Outlook

Developing Custom Adhesive Systems for Transdermal Drug Delivery

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part II

PDA Task Force Issues Guidelines to Aid Isolator Users

Recent Advances in Semisolid Dosage Forms for Dermatological Application

Drug Safety Concerns Shape Manufacturing Policy

Production Information Mangement

Functionality Testing of a Multifunctional Directly Compressible Adjuvant Containing Lactose, Polyvinylpyrrolidone, and Croscarmellose Sodium

Public CROs Craft New Strategies to Achieve Financial and Strategic Objectives

Validation Changes to the USP Assay Method for Ibuprofen Tablets

Systematic Troubleshooting for LC/MS/MS

Product Development Issues of Powders for Injection

Oral Low Molecular Weight Heparin Absorption From Solution and Solid Dosage Forms in Rat, Dog, and Monkey Models

Pharmaceutical Reserch and Manufacturers Association Acceptable Analytical Practice for Analytical Method Transfer

Related Content

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Creates CDER Center for Real-World Evidence Innovation

Susan Haigney

December 13th 2024

Article

The Center for Drug Evaluation and Research’s new center will coordinate and promote use of real-word data in regulatory decisions.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

Feliza Mirasol

December 11th 2024

Article

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.